Arie Mayer

This profile gathers the share dealings of Arie Mayer in Oramed Pharmaceuticals Inc., where the filings describe the role as board member. We count 13 filings; the first trade dates from 1 November 2021 and the latest from 31 December 2025.

On the open market, the record shows 2 purchases worth €18k and 1 sale worth €66k. Netting one side against the other leaves €49k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 10 share grants.

On 5 January 2026 came the latest disclosure, a share grant in Oramed Pharmaceuticals Inc. The last purchase on record was published on 4 April 2023, which is 1,300 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.